BackSkye Bioscience Overview

Skye Bioscience EBIT

EBIT (Earnings Before Interest and Taxes) analysis for SKYE.

Quarterly EBIT

-$12.67M

As of Mar 31, 2026

Annual EBIT (TTM)

-$1.57M
92.6% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)